Elanco Animal Health (ELAN) Competitors $20.46 -0.34 (-1.63%) Closing price 03:59 PM EasternExtended Trading$20.57 +0.11 (+0.53%) As of 04:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ELAN vs. ONC, INSM, BNTX, TEVA, GMAB, SMMT, RDY, ASND, VTRS, and ROIVShould you be buying Elanco Animal Health stock or one of its competitors? The main competitors of Elanco Animal Health include BeOne Medicines (ONC), Insmed (INSM), BioNTech (BNTX), Teva Pharmaceutical Industries (TEVA), Genmab A/S (GMAB), Summit Therapeutics (SMMT), Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), Viatris (VTRS), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry. Elanco Animal Health vs. Its Competitors BeOne Medicines Insmed BioNTech Teva Pharmaceutical Industries Genmab A/S Summit Therapeutics Dr. Reddy's Laboratories Ascendis Pharma A/S Viatris Roivant Sciences BeOne Medicines (NASDAQ:ONC) and Elanco Animal Health (NYSE:ELAN) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership. Do insiders and institutionals hold more shares of ONC or ELAN? 48.6% of BeOne Medicines shares are owned by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are owned by institutional investors. 6.6% of BeOne Medicines shares are owned by company insiders. Comparatively, 0.9% of Elanco Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more volatility and risk, ONC or ELAN? BeOne Medicines has a beta of 0.3, indicating that its stock price is 70% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.65, indicating that its stock price is 65% more volatile than the S&P 500. Does the media favor ONC or ELAN? In the previous week, BeOne Medicines and BeOne Medicines both had 5 articles in the media. BeOne Medicines' average media sentiment score of 1.12 beat Elanco Animal Health's score of 0.41 indicating that BeOne Medicines is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BeOne Medicines 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elanco Animal Health 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate ONC or ELAN? BeOne Medicines currently has a consensus price target of $336.30, suggesting a potential downside of 2.57%. Elanco Animal Health has a consensus price target of $18.33, suggesting a potential downside of 10.39%. Given BeOne Medicines' stronger consensus rating and higher probable upside, analysts plainly believe BeOne Medicines is more favorable than Elanco Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BeOne Medicines 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.11Elanco Animal Health 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.78 Is ONC or ELAN more profitable? Elanco Animal Health has a net margin of 9.68% compared to BeOne Medicines' net margin of -3.89%. Elanco Animal Health's return on equity of 7.04% beat BeOne Medicines' return on equity.Company Net Margins Return on Equity Return on Assets BeOne Medicines-3.89% -1.22% -0.72% Elanco Animal Health 9.68%7.04%3.45% Which has better valuation and earnings, ONC or ELAN? Elanco Animal Health has higher revenue and earnings than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeOne Medicines$3.81B9.93-$644.79M-$1.73-199.52Elanco Animal Health$4.44B2.29$338M$0.8623.79 SummaryElanco Animal Health beats BeOne Medicines on 9 of the 15 factors compared between the two stocks. Get Elanco Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELAN vs. The Competition Export to ExcelMetricElanco Animal HealthMED IndustryMedical SectorNYSE ExchangeMarket Cap$10.16B$4.23B$6.03B$21.67BDividend YieldN/A1.25%5.92%3.56%P/E Ratio23.7926.7976.6229.69Price / Sales2.29229.78583.5965.35Price / Cash8.9428.5338.1924.87Price / Book1.664.7112.554.60Net Income$338M$197.51M$3.30B$1.00B7 Day Performance8.09%2.43%28,086.91%1.74%1 Month Performance14.49%3.05%30,478.87%3.74%1 Year Performance41.69%26.34%35,729.65%13.34% Elanco Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELANElanco Animal Health2.6669 of 5 stars$20.46-1.6%$18.33-10.4%+43.4%$10.16B$4.44B23.799,000News CoverageONCBeOne Medicines1.7847 of 5 stars$337.82+1.0%$336.30-0.4%N/A$36.67B$3.81B-195.2711,000INSMInsmed3.3964 of 5 stars$145.03+0.2%$139.86-3.6%+102.1%$30.60B$363.71M-25.401,271Positive NewsAnalyst ForecastBNTXBioNTech2.731 of 5 stars$98.72+2.6%$134.56+36.3%-14.8%$23.13B$2.98B-61.706,772Positive NewsTEVATeva Pharmaceutical Industries2.5802 of 5 stars$18.87+2.8%$24.71+31.0%+13.4%$21.05B$16.54B-117.9436,830Options VolumeGMABGenmab A/S4.1544 of 5 stars$28.60+1.1%$39.25+37.2%+31.6%$18.14B$3.12B14.372,682Analyst ForecastAnalyst RevisionSMMTSummit Therapeutics3.0484 of 5 stars$19.10+1.1%$31.87+66.8%+1.9%$14.03B$700K-18.91110RDYDr. Reddy's Laboratories3.0782 of 5 stars$14.59-1.9%$16.95+16.2%-10.9%$12.42B$3.81B22.1127,811Positive NewsASNDAscendis Pharma A/S3.4385 of 5 stars$196.42-0.6%$244.36+24.4%+39.2%$12.18B$393.54M-38.071,017High Trading VolumeVTRSViatris1.339 of 5 stars$9.79-1.1%$10.40+6.2%-12.2%$11.54B$14.74B-3.3832,000Positive NewsROIVRoivant Sciences3.816 of 5 stars$14.94-0.7%$19.94+33.5%+38.5%$10.27B$29.05M-21.34860 Related Companies and Tools Related Companies ONC Competitors INSM Competitors BNTX Competitors TEVA Competitors GMAB Competitors SMMT Competitors RDY Competitors ASND Competitors VTRS Competitors ROIV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ELAN) was last updated on 10/2/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredTrump’s Fast-Track Plan: These 3 Stocks Are Set to SoarAI isn't the only game-changer on Wall Street right now. Behind the scenes, President Trump is fast-trackin...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThis Biotech has a clinical approach that intrigues investorsThis biotech is gearing up for Phase 2 trials with a strategy to unlock multiple approvals from one study. ...i2i Marketing Group, LLC | SponsoredExpert Alert: Massive Bubble Could Crash Your WealthOn July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elanco Animal Health Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Elanco Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELAN Stock Alerts